Sugar Excipients Market worth 1,060.6 Million USD by 2021

21/dic/2016 10.32.35 MarketsandMarkets Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

The report "Sugar-Based Excipients Market by Product (Actual Sugars, Sugar Alcohols, Artificial Sweeteners), Type (Powder/Granule, Crystal, Syrup), Functionality (Filler & Diluent, Tonicity Agents), Formulation (Oral, Topical, Parenteral) - Global Forecast to 2021", The sugar excipients market has witnessed healthy growth during the last decade, and is expected to grow at a CAGR of 4.3% between 2016 and 2021 to reach USD 1,060.6 Million by 2021.

 

Growth in this market can be attributed to factors such as increasing use of co-processed excipients, rapid growth in the generics market due to the patent expiration of many blockbuster drugs, and increasing development of orally disintegrating tablets (ODTs).

 

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=242342136

 

The global sugar excipients market is segmented based on product, type, functionality, formulation, and region. Based on product, the market is segmented into actual sugars, sugar alcohols, and artificial sweeteners. Based on type, the market is segmented into powders/granules, direct compression sugars, crystals, and syrups. Similarly, on the basis of functionality, the market is segmented into fillers & diluents, flavoring agents, tonicity agents, and other functionalities. Based on formulation, this market is segmented into oral formulations, parenteral formulations, topical formulations, and other formulations. Based on regions, the sugar excipients market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.

 

In 2015, actual sugar accounted for the largest share of the global sugar excipients market. The sugar alcohols segment is expected to witness the highest growth in the next five years primarily due to the rising use of mannitol in a wide range of dosage forms such as oral and topical, and its high adaptability in emerging formulation technologies, such as orally disintegrating tablets. On the basis of type, powders/granules segment accounted for the large share of the global sugar excipients market. The large share of the powders/granules segment is mainly attributed to its wide use in various types of formulations in the pharmaceutical industry. Based on functionality, fillers & diluents segment accounted for the largest share in this market. The large share of this segment is primarily attributed to huge utilization of fillers and diluents in the development and production of oral dosage forms such as tablets, capsules, and syrups. On the basis of formulation, oral formulations accounted for the largest share in the global sugar excipients market due to it increased use of oral formulations such as tablets, capsules, solutions, and emulsions for various therapeutic areas.

 

Europe is the largest regional segment for the global sugar excipients market. The large share of this regional segment can be attributed to increasing investments in drug development, increasing production of generic drugs, and favorable government initiatives in the region. The market in the Asia-Pacific region is expected to register the highest CAGR owing to the significant growth in the regional healthcare market as well as the pharmaceutical industry, growing scientific base and capability, and favorable government policies, and low-cost manufacturing advantage in this region.

 

Roquette Group (France), DFE Pharma (Germany), BASF SE (Germany), and Ashland Inc. (U.S.), held the major share of the sugar excipients market, and are expected to dominate the market during the forecast period. Other major players in this market are Associated British Foods Plc (U.K.), Cargill, Inc. (U.S.), Colorcon, Inc. (U.S.), FMC Corporation (U.S.), MEGGLE AG (Germany), and The Lubrizol Corporation (U.S.).

 

About MarketsandMarkets

 

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model �“ GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

 

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

 

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

 

Contact:

Mr. Rohan

Markets and Markets

UNIT no 802, Tower no. 7, SEZ

Magarpatta city, Hadapsar

Pune, Maharashtra 411013, India

1-888-600-6441

Email: sales@marketsandmarkets.com

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl